Evidence map›Paper›PMID 23028814›Full record

ArticlePloS one2012

Sequences located within the N-terminus of the PD-linked LRRK2 lead to increased aggregation and attenuation of 6-hydroxydopamine-induced cell death.

Neeraj Pandey, Mark T Fahey, Yuh-Jiin I Jong, Karen L O'Malley

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. LRRK2 and Proteostasis in Parkinson's Disease.International journal of molecular sciences · 2022
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Neeraj PandeyDepartment of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Mark T Fahey
Yuh-Jiin I Jong
Karen L O'Malley
Washington University in St. Louis · US

Funding

MECHANISMS OF NEURONAL DEATH IN PARKINSONS DISEASER01NS039084 · NINDS · WASHINGTON UNIVERSITY · PI O'MALLEY, KAREN L · 1999 to 2012
$3.6M
MECHANISMS OF NEURONAL DEATH IN PARKINSON'S DISEASER56NS039084 · NINDS · WASHINGTON UNIVERSITY · PI O'MALLEY, KAREN L · 2008 to 2008
$304k
Howard Hughes Medical InstituteNINDS NIH HHS NS39084NINDS NIH HHS R01 NS039084NINDS NIH HHS R56 NS039084
6 · The paper itself

Abstract

Clinical symptoms of Parkinson's disease (PD) arise from the loss of substantia nigra neurons resulting in bradykinesia, rigidity, and tremor. Intracellular protein aggregates are a pathological hallmark of PD, but whether aggregates contribute to disease progression or represent a protective mechanism remains unknown. Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been linked to PD in both familial cases and idiopathic cases and aggregates of the LRRK2 protein are present in postmortem PD brain samples. To determine whether LRRK2 contains a region of protein responsible for self-aggregation, two independent, bioinformatic algorithms were used to identify an N-terminal amino acid sequence as being aggregation-prone. Cells subsequently transfected with a construct containing this domain were found to have significantly increased protein aggregation compared to wild type protein or a construct containing only the last half of the molecule. Finally, in support of the hypothesis that aggregates represent a self-protection strategy, aggregated N-terminal LRRK2 constructs significantly attenuated cell death induced by the PD-mimetic, 6-hydroxydopamine (6-OHDA).

Indexed as

AlgorithmsAmino Acid SequenceAnimalsCell DeathCell Line, TumorHumansMesencephalonMiceNeuronsOxidopamineParkinson DiseaseProtein Serine-Threonine KinasesProtein Structure, QuaternaryProtein Structure, TertiarySolubilityStructure-Activity RelationshipOxidopamineProtein Serine-Threonine Kinases

Identifiers

PMID23028814
PMCPMC3441673
OpenAlexW2089793093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.